Complete brain activity map revealed for the first time
On Sept. 3, 2025, The International Brain Laboratory (IBL) researchers published their findings today in two papers in Nature, revealing…
Eliminating tobacco use could reduce age-related macular degeneration
On Aug. 21, 2025, the Institute for Health Metrics and Evaluation (IHME) announced a recent study aimed to…
CIRM awards $4.7 million for vision loss gene therapy
On May 29, 2025, The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
contact lenses give people infrared vision — even with their eyes shut
On My 22, 2025, team led by scientists at the University of Science and Technology of China (USTC)…
spinal tumour removed through a person’s eye socket for the first time
On May 6, 2025, in a first-of-its-kind surgery, a multidisciplinary team led by a University of Maryland Medical…
Diagnostics | Disease | FDA | Medical Device | Non-Profit Research | Ophthalmogy | Rare Disease | Therapeutics
FDA approves ENCELTO, a first-of-its-kind eye implant that slows vision loss in rare eye disease
On Mar. 6, 2025, the U.S. Food and Drug Administration (FDA) announced the approval of ENCELTO (revakinagenetaroretcel-lwey), a…
Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension
On Feb. 19, 2025, Alcon announced the full U.S. commercial availability of Voyager™ DSLT, the first and only…
Biotechnology | Disease | FDA | Neurology | Ophthalmogy | Therapeutics
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
On Feb. 4, 2025, Genentech announced that the U.S. Food and Drug Administration (FDA) had approved Susvimo® (ranibizumab…
Biotechnology | Disease | Medicine | Non-Profit Research | Ophthalmogy | Organ Transplant | Therapeutics
University of Colorado Anschutz Medical Campus-Led Team Receives Up to $46 Million to Develop Innovative Treatment to Cure Blindness
On Dec. 2, 2024, the University of Colorado Anschutz Medical Campus announced it will receive up to $46…
“Prevalence of glaucoma in the U.S. in 2022” study found higher prevalence of the eye disease than previously estimated
On Oct. 18, 2024, a study published in JAMA Ophthalmology, found that approximately 4.22 million people in the…
Gene therapy effective in hereditary blindness
On Sep. 10, 2024, researchers at the Karolinska Institute in Sweden announced a study that shows that gene…
Black history month
Black History Month Celebrates the pioneering accomplishments of James McCune Smith, Rebecca Lee Crumpler, Alexa Canady and Patricia…
Biotechnology | Diagnostics | Disease | Neurology | Non-Profit Research | Ophthalmogy | Therapeutics
CIRM awarded $31 million to fund clinical-stage research for cancers and eye disease
On Apr. 26, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had approved awarding nearly $31…
Eye cell atlas pinpoints where disease-causing genes are expressed, raising hope for inroads against blindness
On Aug. 25, 2023, Harvardﾒs Center for Brain Science announced the ceation of an eye atlas that pinpoints…
Biotechnology | Disease | Medicine | NIH | Ophthalmogy | Therapeutics
NIH study confirmed benefit of supplements for slowing age-related macular degeneration
On Jun. 2, 2022, the National Institutes of Health (NIH) reported that the Age-Related Eye Disease Studies (AREDS…
UCLA clinical trial resulted in a brain implant to help restore visual perception to the blind
On Sept. 18, 2019, researchers from the University of California, Los Angeles (UCLA) announced developing a device geared…
Biotechnology | Diagnostics | Genomics | Medicine | Non-Profit Research | Ophthalmogy | Stem Cell | Therapeutics
Wold Foundation of Wyoming announced a gift of $2.5 million to help in OHSU’s fight against macular degeneration
On Jun. 7, 2018, the Wold Foundation of Wyoming announced a gift of $2.5 million to help in…
Casey Eye Institute researchers develop technology to address blindness
On Apr. 24, 2015, researchers led by David Huang, M.D., Ph.D. at Oregon Health Sciences University’s (OHSU) Casey…
Lucentis approved for treatment of diabetic macular edema
On Aug. 10. 2012, Genentech announced that Lucentis (ranibizumab injection) was approved by the U.S. Food and Drug…
Biology | Diagnostics | Disease | Ophthalmogy | Therapeutics
The Northwest Lions Foundation for Sight & Hearing was renamed as SightLife to better reflect its national and international role
In 2006, the Board of Trustees of the Northwest Lions Foundation for Sight & Hearing renamed Northwest Lions…
OHSU School of Medicine’s Casey Eye Institute received $2.6 million to study glaucoma
On Jan. 29, 2004, researchers at Oregon Health & Science University (OHSU) School of Medicine’s Casey Eye Institute…
OHSU researcher uncovered macular degeneration gene
On Oct. 21, 2003, scientists at Oregon Health Sciences University’s (OHSU) Casey Eye Institute announced they had found…
The Northwest Lions Eye Bank merged with the Montana Eye Bank
In 2001, the Northwest Lions Eye Bank merged with the Montana Eye Bank. SightLife, based in Washington state,…
University of Iowa established the Center for Macular Degeneration
In 1997, the University of Iowa established the Center for Macular Degeneration. The Center was later renamed the…
Brenda Gallie identified the cause of drug-resistant childhood cancer of the retina
In 1996, Dr. Brenda Gallie identified the cause of drug-resistant childhood cancer of the retina, leading to an…
The Lion’s Eye Bank reached milestone: 10,000th corneal transplantation
On Dec. 8, 1994, the Lion’s Eye Bank of Washington, Northern Idaho and Alaska announced that they had…
Biotechnology | Diagnostics | Disease | FDA | Neurology | Ophthalmogy
Omeros Corp was founded
In 1994, Omeros Corp. was founded in Seattle as a biopharmaceutical company committed to discovering, developing and commercializing…
VEGF molecule was discovered
In 1993, Massachusetts Eye and Ear researchers discovered the Vascular endothelial growth factor (VEGF) molecule, implicated in diabetic…
The UC San Diego Shiley Eye Center opened
In 1991, the UC San Diego Shiley Eye Center opened with support by Donald and Darlene Shiley and…
Casey Eye Institute opened at OHSU on Marquam Hill
In 1990, Casey Eye Institute opened on Marquam Hill. Casey’s roots reach back to the end of World…